Streetbeat News

Earnings

NVAX

Novavax projects its full-year 2024 revenue to be between $800 million and $1 billion, aligning closely with the consensus estimate of $969.56 million. The company also anticipates its combined Research & Development (R&D) and Selling, General & Administrative (SG&A) expenses to range from $700 million to $800 million.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:09 pm

GLP

Global Partners President and CEO Eric Slifka announced the company begins 2024 with a strong balance sheet and cash flows, positioning it to continue executing its strategic priorities.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:08 pm

DOV

HOOD

SHAK

SIG

Insiders at Dover, Signet Jewelers, Shake Shack, and Robinhood have recently sold shares. Dover's CFO sold shares after a revenue decline report. Signet Jewelers is set to announce Q4 results soon. Shake Shack's director sold shares following positive Q4 results. Robinhood's Chief Brokerage Officer sold shares after reporting January operating data. Insider sales can indicate various strategic or personal reasons and should be considered as part of a broader investment decision-making process.

Portfolio Pulse from Avi Kapoor

February 28, 2024 | 1:07 pm

AMST

BFX

BGFV

CNXA

CPNG

KTB

LTH

QRTEA

URBN

VIPS

WRBY

In Wednesday's pre-market session, several consumer discretionary stocks showed significant movement. Gainers included Connexa Sports Techs, BowFlex, Qurate Retail, Life Time Group Holdings, Coupang, and Vipshop Holdings, with increases ranging from 8.88% to 22.4%. Losers were Kontoor Brands, Amesite, Urban Outfitters, Big 5 Sporting Goods, Warby Parker, and Smart Share Global, with decreases ranging from 7.88% to 14.1%. The movements were largely attributed to the release of Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 1:06 pm

INGN

OGEN

VTVT

VTYX

In Wednesday's pre-market session, health care stocks saw significant movements. vTv Therapeutics led the gainers with a 104.2% increase, while Oragenics experienced the largest drop, falling 45.3%. Other notable movers include Vivani Medical and Genetic Technologies with substantial gains, and Vicarious Surgical and ProKidney among the losers. Ventyx Biosciences and Inogen reported Q4 earnings, impacting their stock prices.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 1:06 pm

JAMF

PRST

QUIK

In Wednesday's pre-market session, several information technology stocks showed significant movement. Presto Automation, QuickLogic, ARB IOT Group, Perfect, Quantum, and SMX were among the gainers, with increases ranging from 12.57% to 32.3%. On the downside, DoubleVerify Holdings, Jamf Holding, Bit Origin, ASE Tech Holding, ReAlpha Tech Corp, and Inpixon experienced declines between 5.43% and 13.4%. The movements were largely attributed to the release of Q4 earnings reports for several of the companies.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 1:06 pm

FTDR

Frontdoor projects its FY24 revenue to be between $1.81B and $1.84B, which is below the estimated $1.879B.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:05 pm

FTDR

Frontdoor (NASDAQ:FTDR) reported Q4 2023 adjusted EPS of $0.20, surpassing the $0.03 estimate, with sales of $366.00M exceeding the $358.95M forecast. This represents a 7.96% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:04 pm

SWX

Southwest Gas Holdings reported its Q4 adjusted earnings per share (EPS) at $1.13, slightly above the analyst consensus estimate of $1.12, marking a 0.89% beat. However, this represents a 2.59% decrease from the $1.16 EPS reported in the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:03 pm

KOP

Koppers Holdings (KOP) reported Q4 adjusted EPS of $0.67, missing the $0.70 estimate, a 38.53% decrease from last year. However, sales of $513.20M exceeded estimates by 6.11%, marking a 6.34% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:02 pm